Biotech

close up of a beautiful dragonfly
Biotech

AbbVie halts development of Dragonfly cancer asset in midflight

AbbVie has terminated a phase 1 trial of the natural killer-cell engager ABBV-303, licensed from Dragonfly as part of an ongoing partnership.
Darren Incorvaia Oct 29, 2025 1:47pm
theatre stage with red curtains

Novartis’ phase 3 wins in Sjögren's see high placebo effect

Oct 29, 2025 12:03pm
De-Risking Clinical Development Strategic Multipliers in Global Trials

De-Risking Clinical Development: Strategic Multipliers in Global Trials

Oct 27, 2025 8:00am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Regeneron pledges $1B+ for ModeX multispecific antibodies

Oct 29, 2025 11:04am
GeminiGeneratedImagewmbtpzwmbtpzwmbtpng

First FDA IND Milestone Using Human Vascularized Organoid Data

Oct 27, 2025 8:00am
Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Enable Injections, Incyte ink drug delivery collab

Oct 29, 2025 10:15am